Home › Type 2 Diabetes › Arizona
Pag-aaral pangklinika para sa Type 2 Diabetes sa Arizona
25 pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa mga site sa Arizona.
Mga Lungsod sa Arizona
- Tucson13 pag-aaral
- Phoenix8 pag-aaral
- Peoria5 pag-aaral
- Chandler4 pag-aaral
- Gilbert4 pag-aaral
- Scottsdale4 pag-aaral
- Mesa3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Mission Research Institute - Gilbert, Gilbert
- Helios Clinical Research - Paradise Valley, Paradise Valley
- Arizona Liver Health - Peoria 85381, Peoria
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07754461A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Arizona Liver Health - Tucson, Tucson
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07112872EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Arizona Clinical Trials - Chandler, Chandler
- Elite Clinical Studies, Phoenix
- Clinical Research Institute of Arizona, LLC, Sun City West
- at 3 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07064473A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Arizona Clinical Trials, Tucson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07351058A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07881458A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07282600A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- Noble Clinical Research, LLC, Tucson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07915609A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Helios Clinical Research - Phoenix, Phoenix
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tucson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07784270A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tempe
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07662213Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Desert Clinical Research, Mesa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07527650The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Banner Health, Gilbert
- M3 Wake Research, Tucson
Nagre-recruit
Edad 22 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT04101669Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Arizona Clinical Trials - Pecos, Chandler
- Arizona Clinical Trials - Broadway, Tucson
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Gilbert Center for Family Medicine, Gilbert
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07684144Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Gilbert Center For Family Medicine, Gilbert
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07817251A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
- Arizona Clinical Trials, Chandler
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07223333A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Chandler Clinical Trials, Chandler
- Scottsdale Clinical Trials, Scottsdale
- Sun City Research, Sun City
- at 1 pa
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 55 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06112418A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Peoria
- AURORA-2 Clinical Site, Phoenix
- AURORA-2 Clinical Site, Tucson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Sun City
- Research Site, Surprise
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Honor Health, Scottsdale
Nagre-recruitPhase 3
Edad 45 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07797335A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Peoria
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07606066A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- University of Arizona, Tucson
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06739122Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
- Arizona Kidney Disease and Hypertension Center, Phoenix
- Innovative Diabetic Center, Scottsdale
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07187479DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Arizona State University, Phoenix
- Phoenix Children's, Phoenix
Nagre-recruitObservasyonal na pag-aaral
Edad 8 hanggang 15 · Lahat ng kasarian · Na-update May 7, 2026 · NCT06525259Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.